Advanced Breast Cancer: Learn about treatment options.

Filgrastim Pregnancy and Breastfeeding Warnings

Filgrastim is also known as: Neupogen

Filgrastim Pregnancy Warnings

FDA pregnancy category: C Use of filgrastim is not recommended unless the benefit outweighs the risk to the developing fetus.

Animal studies have revealed evidence of maternal toxicity, embryolethality, and fetotoxicity. There are no controlled data in human pregnancy. Filgrastim is only recommended for use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Women who become pregnant during treatment with filgrastim should enroll in Amgen's Pregnancy Surveillance Program. Patients or physicians should call 1-800-77-AMGEN (1-800-772-6436) to enroll. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Filgrastim Breastfeeding Warnings

Women who are nursing during filgrastim treatment should enroll in Amgen's Lactation Surveillance Program. Patients or their physicians should call 1-800-77-AMGEN (1-800-772-6436) to enroll.

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Data not available The effects in the nursing infant are unknown.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)